Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis

Journal of Proteome Research

Volumn 9, Issue 7, 2010, Pages 3664-3670

  Tessem, May Britt ^a   Seln's, Kirsten M ^a   Sjursen, Wenche ^a,b   Tranø, Gerd ^c   Giskeødegård, Guro F ^a   Bathen, Tone F ^a   Gribbestad, Ingrid S ^a   Hofsli, Eva ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c Levanger Hospital   (Norway)

Author keywords

metabolites; metabolomics; MSI; MSS; PCA; PLSDA; promoter MLH1 methylation

Indexed keywords

CREATINE; GLUCOSE; GLYCEROPHOSPHORYLCHOLINE; GLYCINE; INOSITOL; PROTEIN MLH1; TAURINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CHEMOMETRIC ANALYSIS; CLINICAL ARTICLE; COLON ADENOMA; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; METABOLOMICS; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROMOTER REGION; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; ADENOCARCINOMA; BIOLOGY; CLASSIFICATION; COLON; COLONIC NEOPLASMS; CYTOCHEMISTRY; DIFFERENTIAL DIAGNOSIS; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTIVE VALUE; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; REGRESSION ANALYSIS; REPRODUCIBILITY; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; COLON; COLONIC NEOPLASMS; COMPUTATIONAL BIOLOGY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; LEAST-SQUARES ANALYSIS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77954366517     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100176g     Document Type: Article

References (39)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M. J. Cancer statistics, 2009 CA Cancer J. Clin. 2009, 59 (4) 225-49
2. Cancer in Norway 2008. Cancer registry of Norway; http://www. kreftregisteret.no, 2009.
3. Soreide, K.; Janssen, E. A.; Soiland, H.; Korner, H.; Baak, J. P. Microsatellite instability in colorectal cancer Br. J. Surg. 2006, 93 (4) 395-406
4. Boland, C. R.; Thibodeau, S. N.; Hamilton, S. R.; Sidransky, D.; Eshleman, J. R.; Burt, R. W.; Meltzer, S. J.; Rodriguez-Bigas, M. A.; Fodde, R.; Ranzani, G. N.; Srivastava, S. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res. 1998, 58 (22) 5248-57
5. Popat, S.; Hubner, R.; Houlston, R. S. Systematic review of microsatellite instability and colorectal cancer prognosis J. Clin. Oncol. 2005, 23 (3) 609-18
6. Ribic, C. M.; Sargent, D. J.; Moore, M. J.; Thibodeau, S. N.; French, A. J.; Goldberg, R. M.; Hamilton, S. R.; Laurent-Puig, P.; Gryfe, R.; Shepherd, L. E.; Tu, D.; Redston, M.; Gallinger, S. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N. Engl. J. Med. 2003, 349 (3) 247-57
7. Des Guetz, G.; Schischmanoff, O.; Nicolas, P.; Perret, G. Y.; Morere, J. F.; Uzzan, B. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis Eur. J. Cancer 2009, 45 (10) 1890-6
8. Des Guetz, G.; Uzzan, B.; Nicolas, P.; Schischmanoff, O.; Morere, J. F. Microsatellite instability: a predictive marker in metastatic colorectal cancer Target Oncol. 2009, 4 (1) 57-62
9. Kuismanen, S. A.; Holmberg, M. T.; Salovaara, R.; de la Chapelle, A.; Peltomaki, P. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers Am. J. Pathol. 2000, 156 (5) 1773-9
10. Tessem, M. B.; Swanson, M. G.; Keshari, K. R.; Albers, M. J.; Joun, D.; Tabatabai, Z. L.; Simko, J. P.; Shinohara, K.; Nelson, S. J.; Vigneron, D. B.; Gribbestad, I. S.; Kurhanewicz, J. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues Magn. Reson. Med. 2008, 60 (3) 510-6
11. Bathen, T. F.; Jensen, L. R.; Sitter, B.; Fjosne, H. E.; Halgunset, J.; Axelson, D. E.; Gribbestad, I. S.; Lundgren, S. MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status Breast Cancer Res. Treat. 2007, 104 (2) 181-9
12. Sjobakk, T. E.; Johansen, R.; Bathen, T. F.; Sonnewald, U.; Juul, R.; Torp, S. H.; Lundgren, S.; Gribbestad, I. S. Characterization of brain metastases using high-resolution magic angle spinning MRS NMR Biomed. 2008, 21 (2) 175-85
13. Giskeodegard, G. F.; Grinde, M. T.; Sitter, B.; Axelson, D. E.; Lundgren, S.; Fjosne, H. E.; Dahl, S.; Gribbestad, I. S.; Bathen, T. F. Multivariate Modeling and Prediction of Breast Cancer Prognostic Factors Using MR Metabolomics J. Proteome Res. 2010, 9 (2) 972-9
14. Chan, E. C.; Koh, P. K.; Mal, M.; Cheah, P. Y.; Eu, K. W.; Backshall, A.; Cavill, R.; Nicholson, J. K.; Keun, H. C. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS) J. Proteome Res. 2009, 8 (1) 352-61
15. Righi, V.; Durante, C.; Cocchi, M.; Calabrese, C.; Di Febo, G.; Lecce, F.; Pisi, A.; Tugnoli, V.; Mucci, A.; Schenetti, L. Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR spectroscopy and chemometric analyses J. Proteome Res. 2009, 8 (4) 1859-69
16. Piotto, M.; Moussallieh, F. M.; Dillmann, B.; Imperiale, A.; Neuville, A.; Brigand, C.; Bellocq, J. P.; Elbayed, K.; Namer, I. Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy Metabolomics 2009, 5 (3) 292-301
17. Seierstad, T.; Roe, K.; Sitter, B.; Halgunset, J.; Flatmark, K.; Ree, A. H.; Olsen, D. R.; Gribbestad, I. S.; Bathen, T. F. Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy Mol. Cancer 2008, 7, 33
18. Jordan, K. W.; Nordenstam, J.; Lauwers, G. Y.; Rothenberger, D. A.; Alavi, K.; Garwood, M.; Cheng, L. L. Metabolomic characterization of human rectal adenocarcinoma with intact tissue magnetic resonance spectroscopy Dis. Colon Rectum 2009, 52 (3) 520-5
19. Trano, G.; Wasmuth, H. H.; Sjursen, W.; Hofsli, E.; Vatten, L. J. Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population-based study Colorectal Dis. 2009, 11 (5) 456-61
20. Meiboom, S.; Gill, D. Modified spin-echo method for measuring nuclear relaxation times Rev. Sci. Instrum. 1958, 29, 688-691
21. Trano, G.; Sjursen, W.; Wasmuth, H. H.; Hofsli, E.; Vatten, L. J. Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study Br. J. Cancer 2010, 102 (3) 482-8
22. Kennard, R. W.; Stone, L. A. Computer Aided Design of Experiments Technometrics 1969, 11 (1) 137-148
23. Ahlquist, T.; Lind, G. E.; Costa, V. L.; Meling, G. I.; Vatn, M.; Hoff, G. S.; Rognum, T. O.; Skotheim, R. I.; Thiis-Evensen, E.; Lothe, R. A. Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers Mol. Cancer 2008, 7, 94
24. Worthley, D. L.; Whitehall, V. L.; Buttenshaw, R. L.; Irahara, N.; Greco, S. A.; Ramsnes, I.; Mallitt, K. A.; Le Leu, R. K.; Winter, J.; Hu, Y.; Ogino, S.; Young, G. P.; Leggett, B. A. DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer Oncogene 2009, 29, 1653-62
25. Walenta, S.; Schroeder, T.; Mueller-Klieser, W. Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology Curr. Med. Chem. 2004, 11 (16) 2195-204
26. Warburg, O. On the origin of cancer cells Science 1956, 123 (3191) 309-14
27. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; Omenn, G. S.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 2009, 457 (7231) 910-4
28. Glunde, K.; Ackerstaff, E.; Mori, N.; Jacobs, M. A.; Bhujwalla, Z. M. Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions Mol. Pharm. 2006, 3 (5) 496-506 (Pubitemid 44639126)
29. Nakagami, K.; Uchida, T.; Ohwada, S.; Koibuchi, Y.; Suda, Y.; Sekine, T.; Morishita, Y. Increased choline kinase activity and elevated phosphocholine levels in human colon cancer Jpn. J. Cancer Res. 1999, 90 (4) 419-24
30. Wang, Y.; Holmes, E.; Comelli, E. M.; Fotopoulos, G.; Dorta, G.; Tang, H.; Rantalainen, M. J.; Lindon, J. C.; Corthesy-Theulaz, I. E.; Fay, L. B.; Kochhar, S.; Nicholson, J. K. Topographical variation in metabolic signatures of human gastrointestinal biopsies revealed by high-resolution magic-angle spinning 1H NMR spectroscopy J. Proteome Res. 2007, 6 (10) 3944-51
31. Bjerrum, J. T.; Nielsen, O. H.; Hao, F.; Tang, H.; Nicholson, J. K.; Wang, Y.; Olsen, J. Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology J. Proteome Res. 2010, 9 (2) 954-62
32. Yancey, P. H.; Clark, M. E.; Hand, S. C.; Bowlus, R. D.; Somero, G. N. Living with water stress: evolution of osmolyte systems Science 1982, 217 (4566) 1214-22
33. Flogel, U.; Niendorf, T.; Serkowa, N.; Brand, A.; Henke, J.; Leibfritz, D. Changes in organic solutes, volume, energy state, and metabolism associated with osmotic stress in a glial cell line: a multinuclear NMR study Neurochem. Res. 1995, 20 (7) 793-802
34. Moreno, A.; Rey, M.; Montane, J. M.; Alonso, J.; Arus, C. 1H NMR spectroscopy of colon tumors and normal mucosal biopsies; elevated taurine levels and reduced polyethyleneglycol absorption in tumors may have diagnostic significance NMR Biomed. 1993, 6 (2) 111-8
35. Opstad, K. S.; Bell, B. A.; Griffiths, J. R.; Howe, F. A. Taurine: a potential marker of apoptosis in gliomas Br. J. Cancer 2009, 100 (5) 789-94
36. Tanaka, T. Colorectal carcinogenesis: Review of human and experimental animal studies J. Carcinog. 2009, 8, 5
37. Suzuki, K.; Suzuki, I.; Leodolter, A.; Alonso, S.; Horiuchi, S.; Yamashita, K.; Perucho, M. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage Cancer Cell 2006, 9 (3) 199-207
38. Ramirez, N.; Bandres, E.; Navarro, A.; Pons, A.; Jansa, S.; Moreno, I.; Martinez-Rodenas, F.; Zarate, R.; Bitarte, N.; Monzo, M.; Garcia-Foncillas, J. Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions Eur. J. Cancer 2008, 44 (17) 2689-95
39. Kawakami, K.; Ruszkiewicz, A.; Bennett, G.; Moore, J.; Grieu, F.; Watanabe, G.; Iacopetta, B. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer Br. J. Cancer 2006, 94 (4) 593-8